HSP90AA1 and cancer: This study presents a novel function of Cdc7-Db4 in overriding replication stress to activate ATR/ATM signaling, and it opens a new direction to overcome replication stress tolerance in the defects in DNA repair/checkpoint in clinical by using a combination cancer therapy that combines the inhibitors of Cdc7, HSP90, and/or ATR.